FrancophonIA/ELRC3.0 huggingface dataset:
English: In the monotherapy clinical trial comparing lacosamide to carbamazepine CR, the extent of increase in PR interval was comparable between lacosamide and carbamazepine.
Latvian: Monoterapijas klīniskajā pētījumā, salīdzinot lakozamīdu ar kontrolētas izdales karbamazepīnu, PR intervāla apjoma pieaugums bija salīdzināms starp lakozamīdu un kontrolētas izdales karbamazepīnu.
English: Lacosamide Accord may make you dizzy -this could increase the risk of accidental injury or a fall.
Latvian: Lacosamide Accord var izraisīt reiboni, un tas var pastiprināt nejaušu savainojumu vai kritienu risku.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/17/1230/025
Latvian: REĢISTRĀCIJAS APLIECĪBAS NUMURS(-I) EU / 1/17/1230/025
English: If you forget to take Lacosamide Accord
Latvian: Ja esat aizmirsis lietot Lacosamide Accord
English: Convulsion.
Latvian: • Konvulsijas.
English: Ventricular tachyarrhythmia (1)
Latvian: Kambaru tahiaritmija (1)
English: If you are not sure, talk to your doctor or pharmacist before taking this medicine.
Latvian: Šaubu gadījumā pirms šo zāļu lietošanas konsultējieties ar ārstu vai farmaceitu.
English: This is because Lacosamide Accord may make you feel dizzy or cause blurred vision.
Latvian: Lacosamide Accord var izraisīt reiboni vai neskaidru redzi.
English: Each pack of 56 film-coated tablets for a 4-week treatment schedule contains: 14 film-coated tablets of Lacosamide Accord 50 mg 14 film-coated tablets of Lacosamide Accord 100 mg 14 film-coated tablets of Lacosamide Accord 150 mg 14 film-coated tablets of Lacosamide Accord 200 mg
Latvian: Katrs iepakojums pa 56 apvalkotām tabletēm 4 nedēļu ārstēšanas kursam satur: 14 Lacosamide Accord 50 mg apvalkotās tabletes 14 Lacosamide Accord 100 mg apvalkotās tabletes 14 Lacosamide Accord 150 mg apvalkotās tabletes 14 Lacosamide Accord 200 mg apvalkotās tabletes
English: LABORATORI FUNDACIÓ DAU C/ C, 12-14 Pol. Ind. Zona Franca, Barcelona, 08040 Barcelona, Spain or
Latvian: Zona Franca, Barcelona, 08040 Barcelona, Spānija vai
English: Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 300 mg twice a day (600 mg/day).
Latvian: Atkarībā no atbildes reakcijas un panesamības uzturošo devu ik nedēļu var palielināt par 50 mg divas reizes dienā (100 mg/dienā), līdz maksimālajai ieteicamajai dienas devai 300 mg divas reizes dienā (600 mg/dienā).
English: Week 1 Package marked "Week 1"
Latvian: 1.nedēļa Kārbiņa ar atzīmi „1.nedēļa”
English: 08039 Barcelona, Spain
Latvian: Zona Franca 08040 Barcelona SPĀNIJA
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Latvian: B. IZSNIEGSANAS KĀRTĪBAS UN LIETOŠANAS NOSACĪJUMI VAI IEROBEŽOJUMI
English: Week 4 Package marked "Week 4"
Latvian: 4.nedēļa Kārbiņa ar atzīmi „4.nedēļa”
English: Blood tests may show increased levels of liver enzymes and a type of white blood cell (eosinophilia); A widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), and a more severe form causing skin peeling in more than 30 % of the body surface (toxic epidermal necrolysis);
Latvian: • Plaši izplatīti izsitumi ar pūšļiem un ādas lobīšanos, īpaši ap muti, degunu, acīm un dzimumorgāniem (Stīvensa-Džonsona sindroms), un smagāka forma, kad rodas plaša ādas lobīšanās, kas skar vairāk nekā 30 % ķermeņa virsmas (toksiskā epidermālā nekrolīze).
English: However, cases with second and third-degree AV Block associated with lacosamide treatment have been reported in postmarketing experience.
Latvian: Tomēr pēcreģistrācijas periodā ir ziņots par šādiem otrās un trešās pakāpes AV blokādes gadījumiem, kas saistīti ar lakozamīda ārstēšanu.
English: Paediatric population Adolescents and children weighing 50 kg or more
Latvian: Pediatriskā populācija Pusaudži un bērni ar ķermeņa masu 50 kg vai vairāk
English: Based on the analysis of pooled placebo-controlled clinical trials in adjunctive therapy in 1,308 patients with partial-onset seizures, a total of 61.9 % of patients randomized to lacosamide and 35.2 % of patients randomized to placebo reported at least 1 adverse reaction.
Latvian: Pamatojoties uz apkopotiem placebo kontrolētiem papildus terapijas klīniskajiem pētījumiem, kuros piedalījušies 1308 pacienti ar sākotnēji parciālām lēkmēm, kopumā par vismaz vienu nevēlamu blakusparādību ziņojis 61,9 % pacientu, kas pēc nejaušības principa randomizēti lakozamīda grupā, un 35,2 % pacientu, kas pēc nejaušības principa randomizēti placebo grupā.
English: Week 2 Package marked "Week 2"
Latvian: 2.nedēļa Kārbiņa ar atzīmi „2.nedēļa”
English: Instead take Lacosamide Accord at the next time that you would normally take it.
Latvian: Tā vietā lietojiet nākamo Lacosamide Accord devu ieplānotajā laikā.
English: If you weigh 50 kg or more, your doctor may decide to start Lacosamide Accord treatment with a single “loading” dose of 200 mg. You would then start your ongoing maintenance dose 12 hours later.
Latvian: Ja Jūsu ķermeņa masa ir 50 kg vai vairāk, ārsts var uzsākt Lacosamide Accord terapiju ar vienreizēju 200 mg piesātinošo devu.
English: Your doctor may also prescribe a starting dose of 100 mg of Lacosamide Accord twice a day.
Latvian: Ārsts var arī izrakstīt Lacosamide Accord ar sākuma devu 100 mg dienā, lietojot to divas reizes dienā.
English: • fits (seizures), heart beat problems such as a slow, fast or irregular heart beat , coma or a fall in blood pressure with rapid heartbeat and sweating.
Latvian: • lēkmes (krampji), sirds ritma traucējumi, piemēram, palēnināta, paātrināta vai neregulāra sirdsdarbība, koma vai asinsspiediena pazemināšanās ar ātru sirdsdarbību un svīšanu.
English: Aggression Agitation(1) Euphoric mood(1) Psychotic disorder(1) Suicide attempt (1)
Latvian: Agresija Uzbudinājums(1) Eiforisks garastāvoklis(1)
English: OTHER Week 1
Latvian: CITA 1. nedēļa
English: • a medicine for HIV called ritonavir;
Latvian: • zāles HIV infekcijas ārstēšanai: ritonavīrs;
English: Lacosamide Accord contains lacosamide.
Latvian: Lacosamide Accord satur lakozamīdu.
English: This will be until you reach a maintenance dose between 100 mg and 200 mg twice a day.
Latvian: Zāļu devu palielinās, līdz tiks sasniegta uzturošā deva, kas ir no 100 mg līdz 200 mg divas reizes dienā
English: Week 3 Package marked "Week 3"
Latvian: 3.nedēļa Kārbiņa ar atzīmi „3.nedēļa”
English: What Lacosamide Accord looks like and contents of the pack Lacosamide Accord 50 mg are pink, oval, approximately 10.3 x 4.8 mm, coated tablets, debossed “L” on one side and “50” on other side.
Latvian: Lacosamide Accord ārējais izskats un iepakojums Lacosamide Accord 50 mg tabletes ir sārtas, ovālas, aptuveni 10,3 x 4,8 mm lielas apvalkotas tabletes ar iespiestu “L” vienā pusē un “50” otrā pusē.
English: Adolescents and children weighing 50 kg or more, and adults Monotherapy
Latvian: Pusaudži un bērni ar ķermeņa masu 50 kg vai vairāk un pieaugušie Monoterapija
English: In paediatric patients weighing 50 kg or more and in adult patients with mild or moderate renal impairment a loading dose of 200 mg may be considered, but further dose titration (> 200 mg daily) should be performed with caution.
Latvian: Pediatriskajiem pacientiem ar ķermeņa masu 50 kg vai vairāk un pieaugušajiem pacientiem ar viegliem vai vidēji smagiem nieru darbības traucējumiem var apsvērt 200 mg piesātinošo devu, taču turpmāka devas titrēšana (>200 mg dienā) jāveic piesardzīgi.
English: Adolescents and children weighing 50 kg or more and adults When you take Lacosamide Accord on its own
Latvian: Tikai pusaudži un bērni ar ķermeņa masu 50 kg vai vairāk, un pieaugušie Ja lietojat Lacosamide Accord vienu pašu:
English: OTHER Week 4
Latvian: CITA 4. nedēļa
English: Lacosamide Accord 150 mg film coated tablets: EU/1/17/1230/009-012
Latvian: Lacosamide Accord 150 mg apvalkotās tabletes EU/1/17/1230/009-012
English: Lacosamide Accord 200 mg are blue, oval, approximately 16.4 x 7.6 mm, coated tablets, debossed “L” on one side and “200” on other side.
Latvian: Lacosamide Accord 200 mg tabletes ir zilas, ovālas, aptuveni 16,4 x 7,6 mm lielas apvalkotas tabletes ar iespiestu “L” vienā pusē un “200” otrā pusē.
English: Itching, rash.
Latvian: • Nieze, izsitumi.
English: Lacosamide Accord 200 mg film coated tablets: EU/1/17/1230/013-016
Latvian: Lacosamide Accord 200 mg apvalkotās tabletes EU/1/17/1230/013-016
English: Laboratori Fundacio Dau C/ C, 12-14 Pol. Ind. Zona Franca 08040 Barcelona SPAIN
Latvian: Laboratori Fundacio Dau C/ C, 12-14 Pol.
English: What Lacosamide Accord is
Latvian: Kas ir Lacosamide Accord
English: In paediatric patients weighing 50 kg or more and in adult patients with severe renal impairment (CLCR ≤30 ml/min) or with end-stage renal disease, a maximum dose of 250 mg/day is recommended and the dose titration should be performed with caution.
Latvian: Pediatriskajiem pacientiem ar ķermeņa masu 50 kg vai vairāk un pieaugušajiem pacientiem ar smagiem nieru darbības traucējumiem (CLCR ≤ 30 ml/min) vai ar nieru slimību terminālajā stadijā maksimālā ieteicamā deva ir 250 mg dienā, un devas titrēšana jāveic piesardzīgi.
English: Adolescents and children weighing 50 kg or more, and adults
Latvian: Pusaudži un bērni ar ķermeņa masu 50 kg vai vairāk un pieaugušie
English: How to store Lacosamide Accord
Latvian: Kā uzglabāt Lacosamide Accord
English: Lacosamide Accord 100 mg film coated tablets: EU/1/17/1230/005-008
Latvian: Lacosamide Accord 100 mg apvalkotās tabletes EU/1/17/1230/005-008
English: 50 mg tablet: Iron oxide red (E172), iron oxide black (E172), indigo carmine aluminum lake (E132) 100 mg tablet: Iron oxide yellow (E172)
Latvian: 50 mg tablete: sarkanais dzelzs oksīds (E172), melnais dzelzs oksīds (E172), indigokarmīna alumīnija laka (E132)
English: the package marked ‘Week 3' contains 14 tablets of 150 mg, the package marked ‘Week 4' contains 14 tablets of 200 mg .
Latvian: • kārbiņā ar atzīmi „3. nedēļa” ir 14 tabletes (150 mg tabletes)
English: Marketing Authorisation Holder Accord Healthcare S.L.U.
Latvian: REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKS Accord Healthcare S.L.U.
English: Lacosamide Accord 100 mg are dark yellow, oval, approximately 13.0 x 6.0 mm, coated tablets, debossed “L” on one side and “100” on other side.
Latvian: Lacosamide Accord 100 mg tabletes ir tumši dzeltenas, ovālas, aptuveni 13,0 x 6,0 mm lielas apvalkotas tabletes ar iespiestu “L” vienā pusē un “100” otrā pusē.
English: Pink, oval, approximately 10.3 x 4.8 mm, coated tablets, debossed “L” on one side and “50” on other side.
Latvian: Sārtas, ovālas, aptuveni 10,3 x 4,8 mm lielas apvalkotas tabletes ar iespiestu “L” vienā pusē un “50” otrā pusē.
English: Titanium dioxide (E171) Lecithin (soya) Iron oxide red (E172) Iron oxide black (E172) Iron oxide yellow (E172)
Latvian: Titāna dioksīds (E171) Sarkanais dzelzs oksīds (E172) Melnais dzelzs oksīds (E172)
English: Lacosamide Accord 150 mg are salmon, oval, approximately 15.0 x 6.9 mm, coated tablets, debossed “L” on one side and “150” on other side.
Latvian: Lacosamide Accord 150 mg tabletes ir laša krāsas, ovālas, aptuveni 15,0 x 6,9 mm lielas apvalkotas tabletes ar iespiestu “L” vienā pusē un “150” otrā pusē.
English: • a herbal medicine used to treat mild anxiety and depression called St.John's wort.
Latvian: • augu valsts zāles vieglas trauksmes un depresijas ārstēšanai: divšķautņu asinszāle.
English: Adolescents and children weighing 50 kg or more
Latvian: Pusaudži un bērni ar ķermeņa masu 50 kg vai vairāk
English: Blue, oval, approximately 16.4 x 7.6 mm, coated tablets, debossed “L” on one side and “200” on other side.
Latvian: Zilas, ovālas, aptuveni 16,4 x 7,6 mm lielas apvalkotas tabletes ar iespiestu “L” vienā pusē un “200” otrā pusē.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Lacosamide Accord 50 mg film-coated tablets One film-coated tablet contains 50 mg lacosamide.
Latvian: KVALITATĪVAIS UN KVANTITATĪVAIS SASTĀVS Lacosamide Accord 50 mg apvalkotās tabletes Viena apvalkotā tablete satur 50 mg lakozamīda (Lacosamidum).
English: 200 mg (1 tablet Lacosamide Accord 200 mg)
Latvian: 200 mg (1 Lacosamide Accord 200 mg tablete)
English: 150 mg (1 tablet Lacosamide Accord 150 mg)
Latvian: 150 mg (1 Lacosamide Accord 150 mg tablete)
English: OTHER Week 2
Latvian: CITA 2. nedēļa
English: Blood tests may show a severe decrease in a specific class of white blood cells (agranulocytosis); A serious skin reaction which may include a high temperature and other flu-like symptoms, a rash on the face, extended rash, swollen glands (enlarged lymph nodes).
Latvian: • Nopietnas ādas reakcijas, kas var ietvert augstu temperatūru un citus gripai līdzīgus simptomus, izsitumus uz sejas, izplatītus izsitumus ,pietūkušus limfmezglus (palielinātus limfmezglus).
English: Dark yellow, oval, approximately 13.0 x 6.0 mm, coated tablets, debossed “L” on one side and “100” on other side.
Latvian: Tumši dzeltenas, ovālas, aptuveni 13,0 x 6,0 mm lielas apvalkotas tabletes ar iespiestu “L” vienā pusē un “100” otrā pusē.
English: 50 mg (1 tablet Lacosamide Accord 50 mg)
Latvian: 50 mg (1 Lacosamide Accord 50 mg tablete)
English: Salmon, oval, approximately 15.0 x 6.9 mm, coated tablets, debossed “L” on one side and “150” on other side.
Latvian: Laša krāsas, ovālas, aptuveni 15,0 x 6,9 mm lielas apvalkotas tabletes ar iespiestu “L” vienā pusē un “150” otrā pusē.
English: Initiation of lacosamide treatment with a loading dose
Latvian: Lakozamīda lietošanas uzsākšana ar piesātinošo devu
English: Stevens-Johnson syndrome(1) Toxic epidermal necrolysis(1)
Latvian: StīvensaDžonsona sindroms(1)
English: If you stop taking Lacosamide Accord
Latvian: Ja pārtraucat lietot Lacosamide Accord
English: Lacosamide Accord 50 mg Lacosamide Accord 100 mg Lacosamide Accord 150 mg Lacosamide Accord 200 mg film-coated tablets lacosamide
Latvian: Lacosamide Accord 50 mg Lacosamide Accord 100 mg Lacosamide Accord 150 mg Lacosamide Accord 200 mg apvalkotās tabletes lacosamidum
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS TREATMENT INITIATION PACK ONLY Blister label - week 2
Latvian: MINIMĀLĀ INFORMĀCIJA IZVIETOJAMĀ UZ BLISTERA VAI PLĀKSNĪTES ATTIECAS TIKAI UZ IEPAKOJUMU ĀRSTĒŠANAS UZSĀKŠANAI Blistera marķējums - 2. nedēļai
English: Drug hypersensitivity(1)
Latvian: Paaugstināta jutība pret zālēm(1)
English: Pharmacotherapeutic group: antiepileptics, other antiepileptics, ATC code: N03AX18 Mechanism of action
Latvian: Farmakoterapeitiskā grupa: pretepilepsijas līdzekļi, citi pretepilepsijas līdzekļi;
English: One tablet of Lacosamide Accord 50 mg contains 50 mg lacosamide.
Latvian: Viena Lacosamide Accord 50 mg tablete satur 50 mg lakozamīda.
English: 100 mg (1 tablet Lacosamide Accord 100 mg)
Latvian: 100 mg (1 Lacosamide Accord 100 mg tablete)
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS TREATMENT INITIATION PACK ONLY Blister label - week 1
Latvian: MINIMĀLĀ INFORMĀCIJA IZVIETOJAMĀ UZ BLISTERA VAI PLĀKSNĪTES ATTIECAS TIKAI UZ IEPAKOJUMU ĀRSTĒŠANAS UZSĀKŠANAI Blistera marķējums - 1. nedēļai
English: TREATMENT INITIATION PACK ONLY Intermediate Carton
Latvian: ATTIECAS TIKAI UZ IEPAKOJUMU ĀRSTĒŠANAS UZSĀKŠANAI Vidējais iepakojums
English: OTHER Week 3
Latvian: CITA 3. nedēļa
English: One tablet of Lacosamide Accord 200 mg contains 200 mg lacosamide.
Latvian: Viena Lacosamide Accord 200 mg tablete satur 200 mg lakozamīda.
English: 150 mg tablet: Iron oxide red (E172), iron oxide black (E172), iron oxide yellow (E172) 200 mg tablet: Indigo carmine aluminum lake (E132)
Latvian: 150 mg tablete: sarkanais dzelzs oksīds (E172), melnais dzelzs oksīds (E172), dzeltenais dzelzs oksīds (E172)
English: EU/1/17/1230/001 EU/1/17/1230/002 EU/1/17/1230/003 EU/1/17/1230/004 EU/1/17/1230/017 EU/1/17/1230/018
Latvian: EU/1/17/1230/001-004 EU/1/17/1230/017-018
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS TREATMENT INITIATION PACK ONLY Blister label - week 3
Latvian: MINIMĀLĀ INFORMĀCIJA IZVIETOJAMĀ UZ BLISTERA VAI PLĀKSNĪTES ATTIECAS TIKAI UZ IEPAKOJUMU ĀRSTĒŠANAS UZSĀKŠANAI Blistera marķējums - 3. nedēļai
English: One tablet of Lacosamide Accord 100 mg contains 100 mg lacosamide.
Latvian: Viena Lacosamide Accord 100 mg tablete satur 100 mg lakozamīda.
English: One tablet of Lacosamide Accord 150 mg contains 150 mg lacosamide.
Latvian: Viena Lacosamide Accord 150 mg tablete satur 150 mg lakozamīda.
English: Single loading dose
Latvian: Vienreizējā piesātinošā deva
English: What Lacosamide Accord is used for
Latvian: Kādam nolūkam Lacosamide Accord lieto
English: Decreased feeling or sensitivity, difficulty in articulating words, disturbance in attention; Noise in the ear such as buzzing, ringing or whistling;
Latvian: • Samazināts jutīgums, grūtības skaidri izrunāt vārdus, uzmanības traucējumi
English: Lacosamide Accord 150 mg 1 film-coated tablet contains 150 mg lacosamide.
Latvian: Lacosamide Accord 150 mg 1 apvalkotā tablete satur 150 mg lakozamīda.
English: NAME OF THE MEDICINAL PRODUCT Lacosamide Accord 50 mg film-coated tablets lacosamide
Latvian: ZĀĻU NOSAUKUMS Lacosamide Accord 50 mg apvalkotās tabletes lacosamidum
English: Maximum recommended dose in patients < 20 kg up to 12 mg/kg/day Maximum recommended dose in patients ≥ 20 kg to < 30 kg up to 10 mg/kg/day
Latvian: Maksimālā ieteicamā deva pacientiem ar ķermeņa masu < 20 kg līdz 12 mg/kg/dienā
English: • At the request of the European Medicines Agency
Latvian: Atjaunināts RPP jāiesniedz: • pēc Eiropas Zāļu aģentūras pieprasījuma;
English: Lacosamide Accord 150 mg film-coated tablets
Latvian: Lacosamide Accord 150 mg apvalkotās tabletes
English: Lacosamide Accord 150 mg film-coated tablets lacosamide
Latvian: Lacosamide Accord 150 mg apvalkotās tabletes lacosamidum
English: Lacosamide Accord 100 mg 1 film-coated tablet contains 100 mg lacosamide.
Latvian: Lacosamide Accord 100 mg 1 apvalkotā tablete satur 100 mg lakozamīda.
English: 1 film-coated tablet contains 200 mg lacosamide.
Latvian: Viena apvalkotā tablete satur 200 mg lakozamīda (Lacosamidum).
English: Bradycardia(1,2) Atrial Fibrillation Atrial Flutter (1,2)
Latvian: Priekškambaru fibrilācija(1,2)
English: 50 mg: Each film-coated tablet contains 0.105 mg of lecithin (soya) 100 mg: Each film-coated tablet contains 0.210 mg of lecithin (soya) 150 mg: Each film-coated tablet contains 0.315 mg of lecithin (soya) 200 mg: Each film-coated tablet contains 0.420 mg of lecithin (soya) For the full list of excipients, see section 6.1.
Latvian: 150 mg: katra apvalkotā tablete satur 0,315 mg lecitīna (sojas).
English: Microcrystalline cellulose Hydroxy propyl cellulose-L Hydroxy propyl cellulose (low substituted) Silica, colloidal, anhydrous Crospovidone
Latvian: Mikrokristāliskā celuloze Hidroksipropilceluloze-L Hidroksipropilceluloze (mazaizvietota)
English: Lacosamide Accord 50 mg 1 film-coated tablet contains 50 mg lacosamide.
Latvian: Lacosamide Accord 50 mg 1 apvalkotā tablete satur 50 mg lakozamīda.
English: Each film-coated tablet contains 200 mg lacosamide.
Latvian: Katra apvalkotā tablete satur 200 mg lakozamīda.
English: Lacosamide Accord 200 mg 1 film-coated tablet contains 200 mg lacosamide.
Latvian: Lacosamide Accord 200 mg 1 apvalkotā tablete satur 200 mg lakozamīda.
English: Lacosamide Accord 100 mg film-coated tablets lacosamide
Latvian: Lacosamide Accord 100 mg apvalkotās tabletes lacosamidum
English: 1 film-coated tablet contains 50 mg lacosamide.
Latvian: Viena apvalkotā tablete satur 50 mg lakozamīda (Lacosamidum).
English: Taking Lacosamide Accord
Latvian: Lacosamide Accord lietošana
English: Maximum recommended dose in patients < 40 kg up to 12 mg/kg/day Maximum recommended dose in patients ≥ 40 kg to < 50 kg up to 10 mg/kg/day
Latvian: Maksimālā ieteicamā deva pacientiem ar ķermeņa masu < 40 kg līdz 12 mg/kg/dienā
English: 1 film-coated tablet contains 100 mg lacosamide.
Latvian: Viena apvalkotā tablete satur 100 mg lakozamīda (Lacosamidum).
English: Lacosamide Accord 50 mg film-coated tablets lacosamide
Latvian: Lacosamide Accord 50 mg apvalkotās tabletes lacosamidum
English: Each film-coated tablet contains 150 mg lacosamide.
Latvian: Katra apvalkotā tablete satur 150 mg lakozamīda.
English: Lacosamide Accord 200 mg film-coated tablets One film-coated tablet contains 200 mg lacosamide.
Latvian: Lacosamide Accord 200 mg apvalkotās tabletes Viena apvalkotā tablete satur 200 mg lakozamīda (Lacosamidum).
English: Titanium dioxide (E171) Lecithin (soya) Iron oxide yellow (E172)
Latvian: Dzeltenais dzelzs oksīds (E172)
English: 1 film-coated tablet contains 150 mg lacosamide.
Latvian: Viena apvalkotā tablete satur 150 mg lakozamīda (Lacosamidum).
English: Lacosamide Accord 200 mg film-coated tablets
Latvian: Lacosamide Accord 200 mg apvalkotās tabletes
English: Lacosamide Accord 200 mg film-coated tablets lacosamide
Latvian: Lacosamide Accord 200 mg apvalkotās tabletes lacosamidum
English: Lacosamide Accord 100 mg film-coated tablets
Latvian: Lacosamide Accord 100 mg apvalkotās tabletes
English: Each film-coated tablet contains 50 mg lacosamide.
Latvian: Katra apvalkotā tablete satur 50 mg lakozamīda.
English: Gait disturbance Asthenia Fatigue
Latvian: Gaitas traucējumi Astēnija
English: Lacosamide Accord 50 mg film-coated tablets
Latvian: Lacosamide Accord 50 mg apvalkotās tabletes
English: Each film-coated tablet contains 100 mg lacosamide.
Latvian: Katra apvalkotā tablete satur 100 mg lakozamīda.
English: Fall Skin laceration Contusion (1) Adverse reactions reported in post marketing experience.
Latvian: (1) Blakusparādības, par kurām ziņots pēcreģistrācijas pieredzē.
English: When you take Lacosamide Accord with other antiepileptic medicines Start of the treatment (the first 4 weeks)
Latvian: Ja lietojat Lacosamide Accord kopā ar citām pretepilepsijas zālēm:
English: Lacosamide Accord 150 mg film-coated tablets One film-coated tablet contains 150 mg lacosamide.
Latvian: Lacosamide Accord 150 mg apvalkotās tabletes Viena apvalkotā tablete satur 150 mg lakozamīda (Lacosamidum).
English: Paraesthesia
Latvian: Depresija
English: Lacosamide Accord 100 mg film-coated tablets One film-coated tablet contains 100 mg lacosamide.
Latvian: Lacosamide Accord 100 mg apvalkotās tabletes Viena apvalkotā tablete satur 100 mg lakozamīda (Lacosamidum).
English: The treatment initiation pack contains 56 film-coated tablets in 4 packages: the package marked ‘Week 1'contains 14 tablets of 50 mg, the package marked ‘Week 2' contains 14 tablets of 100 mg,
Latvian: • kārbiņā ar atzīmi „1. nedēļa” ir 14 tabletes (50 mg tabletes)
English: Nausea Vomiting Constipation
Latvian: Kritieni Ādas plīsumi Sasitums
English: Treatment initiation pack (in adolescent and children weighing 50 kg or more and adults only) Lacosamide Accord 50 mg film-coated tablets
Latvian: Iepakojums ārstēšanas uzsākšanai (tikai pusaudžiem un bērniem ar ķermeņa masu 50 kg vai vairāk, un pieaugušajiem)
English: NAME OF THE MEDICINAL PRODUCT Lacosamide Accord 50 mg film-coated tablets Lacosamide Accord 100 mg film-coated tablets Lacosamide Accord 150 mg film-coated tablets Lacosamide Accord 200 mg film-coated tablets
Latvian: Lacosamide Accord 50 mg apvalkotās tabletes Lacosamide Accord 100 mg apvalkotās tabletes Lacosamide Accord 150 mg apvalkotās tabletes Lacosamide Accord 200 mg apvalkotās tabletes lacosamidum
English: Depression Confusional state Insomnia(1)
Latvian: Apjukuma stāvoklis Bezmiegs(1)
English: Rash(1)
Latvian: Nātrene(1)
English: Eating less than usual;
Latvian: • Samazināta ēstgriba.
English: Others
Latvian: Sākumdeva
English: In comparison, plasma clearance was estimated at 1.92 L/h in adults (70 kg body weight).
Latvian: Tipiskais noteiktais plazmas klīrenss bērniem ar ķermeņa masu 20 kg, 30 kg un 50 kg, attiecīgi bija 1,04 l/h, 1,32 l/h un 1,86 l/h. Salīdzinājumā plazmas klīrenss pieaugušajiem (ar ķermeņa masu 70 kg) tika noteikts 1,92 l/h.
English: Flatulence Dyspepsia Dry mouth Diarrhoea
Latvian: Bezūdens koloidālais silīcija dioksīds Krospovidons
English: --P1 Live gEP-P tkP-P double-gene deleted Bovine Herpes Virus type 1 (BoHV-1), strain CEDDEL: 10P6.3P - 10P7.3P CCIDR50 Rper 2 ml (gEP-P: deleted glycoprotein E; tkP-P: deleted thymidine kinase; CCID: cell culture infectious dose)
Latvian: --P1 Dzīvs gEP-P tkP-P Liellopu Herpes Vīrusa tips 1 (BoVHV-1) ar dubultu gēnu delēciju, celms CEDDEL: 10P6.3P - 10P7.3P CCIDR50